Nabriva Therapeutics PLC (NASDAQ:NBRV)
| 1.72 Delayed Data As of Mar 23 |  0.00 / 0.00%Today’s Change | 1.22 Today|||52-Week Range 12.80 | -8.99% Year-to-Date |
Latest NBRV News | Press Releases
No recent news for Nabriva Therapeutics PLC.
Today’s Trading
| Previous close | 1.72 |
| Today’s open | 1.72 |
| Day’s range | 1.72 - 1.72 |
| Volume | 4 |
| Average volume (3 months) | 68,629 |
| Market cap | $4.9M |
Data as of 3:02pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | +78.91% |
| Earnings growth (this year) | +37.96% |
| Earnings growth (next 5 years) | +39.90% |
| Revenue growth (last year) | +474.80% |
| P/E ratio | NM |
| Price/Sales | 0.90 |
| Price/Book | 0.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATXIAvenue Therapeutics ... | +0.00 | +0.48% |
| CYCCPCyclacel Pharmaceuti... | 0.00 | 0.00% |
| ACRXAcelRx Pharmaceutica... | -0.03 | -3.63% |
| HSTOHistogen Inc | +0.16 | +15.84% |
Data as of 3:51pm ET, 03/24/2023
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$4.03 |
| Annual revenue (last year) | $28.9M |
| Annual profit (last year) | -$49.5M |
| Net profit margin | -171.14% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
